ORTHOPEDIATRICS CORP (KIDS) Fundamental Analysis & Valuation

NASDAQ:KIDS • US68752L1008

Current stock price

15.94 USD
-0.07 (-0.44%)
At close:
15.94 USD
0 (0%)
After Hours:

This KIDS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. KIDS Profitability Analysis

1.1 Basic Checks

  • In the past year KIDS has reported negative net income.
  • KIDS had a negative operating cash flow in the past year.
  • In the past 5 years KIDS reported 4 times negative net income.
  • In the past 5 years KIDS always reported negative operating cash flow.
KIDS Yearly Net Income VS EBIT VS OCF VS FCFKIDS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M -40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -7.80%, KIDS is in the better half of the industry, outperforming 64.89% of the companies in the same industry.
  • With a decent Return On Equity value of -11.44%, KIDS is doing good in the industry, outperforming 68.09% of the companies in the same industry.
Industry RankSector Rank
ROA -7.8%
ROE -11.44%
ROIC N/A
ROA(3y)-6.86%
ROA(5y)-5.12%
ROE(3y)-9.22%
ROE(5y)-6.91%
ROIC(3y)N/A
ROIC(5y)N/A
KIDS Yearly ROA, ROE, ROICKIDS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200

1.3 Margins

  • With an excellent Gross Margin value of 73.05%, KIDS belongs to the best of the industry, outperforming 82.98% of the companies in the same industry.
  • KIDS's Gross Margin has been stable in the last couple of years.
  • KIDS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y-1.14%
KIDS Yearly Profit, Operating, Gross MarginsKIDS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. KIDS Health Analysis

2.1 Basic Checks

  • KIDS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, KIDS has more shares outstanding
  • Compared to 5 years ago, KIDS has more shares outstanding
  • Compared to 1 year ago, KIDS has a worse debt to assets ratio.
KIDS Yearly Shares OutstandingKIDS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
KIDS Yearly Total Debt VS Total AssetsKIDS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of 1.51, we must say that KIDS is in the distress zone and has some risk of bankruptcy.
  • KIDS's Altman-Z score of 1.51 is in line compared to the rest of the industry. KIDS outperforms 52.66% of its industry peers.
  • KIDS has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
  • KIDS has a Debt to Equity ratio of 0.29. This is comparable to the rest of the industry: KIDS outperforms 51.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Altman-Z 1.51
ROIC/WACCN/A
WACC8.4%
KIDS Yearly LT Debt VS Equity VS FCFKIDS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • KIDS has a Current Ratio of 5.55. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
  • KIDS has a better Current ratio (5.55) than 78.19% of its industry peers.
  • KIDS has a Quick Ratio of 2.65. This indicates that KIDS is financially healthy and has no problem in meeting its short term obligations.
  • KIDS has a Quick ratio of 2.65. This is comparable to the rest of the industry: KIDS outperforms 58.51% of its industry peers.
Industry RankSector Rank
Current Ratio 5.55
Quick Ratio 2.65
KIDS Yearly Current Assets VS Current LiabilitesKIDS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. KIDS Growth Analysis

3.1 Past

  • The earnings per share for KIDS have decreased by -3.68% in the last year.
  • Looking at the last year, KIDS shows a quite strong growth in Revenue. The Revenue has grown by 15.45% in the last year.
  • Measured over the past years, KIDS shows a very strong growth in Revenue. The Revenue has been growing by 27.16% on average per year.
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.68%
Revenue 1Y (TTM)15.45%
Revenue growth 3Y24.56%
Revenue growth 5Y27.16%
Sales Q2Q%16.97%

3.2 Future

  • KIDS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.02% yearly.
  • KIDS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.85% yearly.
EPS Next Y31.26%
EPS Next 2Y24.33%
EPS Next 3Y5.47%
EPS Next 5Y18.02%
Revenue Next Year12.62%
Revenue Next 2Y12.24%
Revenue Next 3Y12.22%
Revenue Next 5Y11.85%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
KIDS Yearly Revenue VS EstimatesKIDS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
KIDS Yearly EPS VS EstimatesKIDS Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. KIDS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KIDS. In the last year negative earnings were reported.
  • Also next year KIDS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KIDS Price Earnings VS Forward Price EarningsKIDS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KIDS Per share dataKIDS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.33%
EPS Next 3Y5.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. KIDS Dividend Analysis

5.1 Amount

  • KIDS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KIDS Fundamentals: All Metrics, Ratios and Statistics

ORTHOPEDIATRICS CORP

NASDAQ:KIDS (4/9/2026, 8:00:03 PM)

After market: 15.94 0 (0%)

15.94

-0.07 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners68.02%
Inst Owner Change0%
Ins Owners5.07%
Ins Owner Change2.18%
Market Cap402.96M
Revenue(TTM)236.35M
Net Income(TTM)-39.65M
Analysts82.67
Price Target25.39 (59.28%)
Short Float %5.55%
Short Ratio6.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.48%
Min EPS beat(2)-89.58%
Max EPS beat(2)-25.37%
EPS beat(4)1
Avg EPS beat(4)-28.04%
Min EPS beat(4)-89.58%
Max EPS beat(4)2.89%
EPS beat(8)3
Avg EPS beat(8)-30.23%
EPS beat(12)6
Avg EPS beat(12)-14.23%
EPS beat(16)8
Avg EPS beat(16)-4.59%
Revenue beat(2)1
Avg Revenue beat(2)-1.52%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)0.75%
Revenue beat(4)1
Avg Revenue beat(4)-1.52%
Min Revenue beat(4)-3.78%
Max Revenue beat(4)0.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.23%
Revenue beat(12)4
Avg Revenue beat(12)-0.19%
Revenue beat(16)5
Avg Revenue beat(16)-0.9%
PT rev (1m)3.7%
PT rev (3m)3.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.09%
EPS NY rev (1m)0%
EPS NY rev (3m)8.15%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.7
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 2.52
EV/EBITDA N/A
EPS(TTM)-1.69
EYN/A
EPS(NY)-1.16
Fwd EYN/A
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS9.35
BVpS13.71
TBVpS6.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -7.8%
ROE -11.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.05%
FCFM N/A
ROA(3y)-6.86%
ROA(5y)-5.12%
ROE(3y)-9.22%
ROE(5y)-6.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.5%
GM growth 5Y-1.14%
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.61%
Cap/Sales 4.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.55
Quick Ratio 2.65
Altman-Z 1.51
F-Score4
WACC8.4%
ROIC/WACCN/A
Cap/Depr(3y)79.98%
Cap/Depr(5y)93.28%
Cap/Sales(3y)8.25%
Cap/Sales(5y)9.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.68%
EPS Next Y31.26%
EPS Next 2Y24.33%
EPS Next 3Y5.47%
EPS Next 5Y18.02%
Revenue 1Y (TTM)15.45%
Revenue growth 3Y24.56%
Revenue growth 5Y27.16%
Sales Q2Q%16.97%
Revenue Next Year12.62%
Revenue Next 2Y12.24%
Revenue Next 3Y12.22%
Revenue Next 5Y11.85%
EBIT growth 1Y1.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year165.16%
EBIT Next 3Y45.1%
EBIT Next 5Y31.76%
FCF growth 1Y61.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.07%
OCF growth 3YN/A
OCF growth 5YN/A

ORTHOPEDIATRICS CORP / KIDS Fundamental Analysis FAQ

What is the fundamental rating for KIDS stock?

ChartMill assigns a fundamental rating of 3 / 10 to KIDS.


Can you provide the valuation status for ORTHOPEDIATRICS CORP?

ChartMill assigns a valuation rating of 0 / 10 to ORTHOPEDIATRICS CORP (KIDS). This can be considered as Overvalued.


How profitable is ORTHOPEDIATRICS CORP (KIDS) stock?

ORTHOPEDIATRICS CORP (KIDS) has a profitability rating of 2 / 10.


What is the financial health of ORTHOPEDIATRICS CORP (KIDS) stock?

The financial health rating of ORTHOPEDIATRICS CORP (KIDS) is 3 / 10.


Can you provide the expected EPS growth for KIDS stock?

The Earnings per Share (EPS) of ORTHOPEDIATRICS CORP (KIDS) is expected to grow by 31.26% in the next year.